TRANSCAN-3 (JTC 2021) focuses on:
«Next generation cancer immunotherapy: targeting the tumour microenvironment»
TRANSCAN-3 aims at promoting highly innovative and ambitious collaborative projects in translational cancer research at European and international level, and considers that, based on the previous grounds, it is timely and relevant to foster the translation of new knowledge on tumour microenvironment functions into clinical practices. The expected impact of the call is to improve the efficacy of personalized treatment of cancer patients through the development of new tools and targeted immunotherapy strategies, based on a better understanding of tumour microenvironment functions and of their impact on the disease course.
TRANSCAN-3 JTC 2021 will be implemented through a two-stage submission procedure: preproposals and full proposals. Both pre- and full proposals must be written in English and submitted to the JCS by the coordinator through the PT-Outline electronic submission system exclusively. Full proposals will only be accepted from applicants explicitly invited by the JCS to submit.
Deadline for pre-proposal submission: 29 June 2021 at 12:00 (CEST)
Deadline for full-proposal submission: 20 December 2021 at 12:00 (CET)